Showing 1 - 20 results of 97,551 for search '(( significant ((gap decrease) OR (_ decrease)) ) OR ( significant decision analysis ))', query time: 0.57s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    Regenerating axons are increased by ATRA and decreased by clodronate. by Valeria De La Rosa-Reyes (6658613)

    Published 2021
    “…Compared to PBS-treated, the number of regenerating axons is doubled by ATRA treatment, decreased by 30% by clodronate, and, in the case of ATRA combined with clodronate, is not significantly different.…”
  6. 6
  7. 7

    Overexpression of Gαq decreases cell number and cell size. by Dharsan K. Soundarrajan (11632145)

    Published 2021
    “…Student t-test was used for statistical significance testing.</p> <p>(TIF)</p>…”
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Syndecan ectodomain fragments decrease endothelial resistance via rho kinase. by Melanie Jannaway (6703577)

    Published 2019
    “…(B) rhS3ED fragments induced a highly significant drop in TER (n = 6, p<0.0001). (C) rhS4ED fragments significantly decreased TER (n = 8, p = 0.0002). …”
  14. 14

    Image_1_The significance of time interval between perioperative SOX/XELOX chemotherapy and clinical decision model in gastric cancer.pdf by Jun-Bing Chen (14296940)

    Published 2022
    “…Patients’ 5-year overall survival (OS) significantly decreased as trichotomous PECTI increased (78.6% vs 66.7% vs 55.7%, P = .02). …”
  15. 15

    Image_2_The significance of time interval between perioperative SOX/XELOX chemotherapy and clinical decision model in gastric cancer.pdf by Jun-Bing Chen (14296940)

    Published 2022
    “…Patients’ 5-year overall survival (OS) significantly decreased as trichotomous PECTI increased (78.6% vs 66.7% vs 55.7%, P = .02). …”
  16. 16

    Table_2_The significance of time interval between perioperative SOX/XELOX chemotherapy and clinical decision model in gastric cancer.docx by Jun-Bing Chen (14296940)

    Published 2022
    “…Patients’ 5-year overall survival (OS) significantly decreased as trichotomous PECTI increased (78.6% vs 66.7% vs 55.7%, P = .02). …”
  17. 17

    Table_3_The significance of time interval between perioperative SOX/XELOX chemotherapy and clinical decision model in gastric cancer.docx by Jun-Bing Chen (14296940)

    Published 2022
    “…Patients’ 5-year overall survival (OS) significantly decreased as trichotomous PECTI increased (78.6% vs 66.7% vs 55.7%, P = .02). …”
  18. 18

    Table_1_The significance of time interval between perioperative SOX/XELOX chemotherapy and clinical decision model in gastric cancer.docx by Jun-Bing Chen (14296940)

    Published 2022
    “…Patients’ 5-year overall survival (OS) significantly decreased as trichotomous PECTI increased (78.6% vs 66.7% vs 55.7%, P = .02). …”
  19. 19

    Subgroup analysis – Political affiliation. by Mehdi Mourali (10170245)

    Published 2025
    “…When are individuals more likely to support equal treatment algorithms (ETAs), characterized by higher predictive accuracy, and when do they prefer equal impact algorithms (EIAs) that reduce performance gaps between groups? A randomized conjoint experiment and a follow-up choice experiment revealed that support for the EIAs decreased sharply as their accuracy gap grew, although impact parity was prioritized more when ETAs produced large outcome discrepancies. …”
  20. 20